Comments
Roche, Lilly drugs set for Alzheimer's prevention trial
11.10.2012. | NEW YORK (Reuters) - Experimental Alzheimer's drugs from Roche Holding AG and Eli Lilly & Co have been selected for a high-profile clinical trial to test whether it is possible to prevent the brain-wasting disease from developing in at-risk patients....
